IN VITRO LABS S.A.

Name

IN VITRO LABS S.A.

Legal name

In Vitro Labs A.E.

Website

https://invitrolabs.gr

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Medical Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)

akta.pro secondary industry

Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD)

Keywords

• Clinical laboratory diagnostics
• Molecular diagnostics testing
• Medical testing services
• COVID-19 PCR testing
• Immunology microbiology testing

Headquarters

HQ city

Peristeri

HQ country

Greece

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Diagnostic Laboratory Services: In Vitro Labs generates revenue through providing medical diagnostic testing services to patients and healthcare providers, operating as a medical anonymous company (Ιατρική Ανώνυμη Εταιρεία) offering comprehensive laboratory testing services in Greece, Cyprus, and the Balkans region.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

IN VITRO LABS S.A. is a Greek medical diagnostic laboratory operating a 1600 sq.m. ISO 15189:2012 accredited facility in Peristeri, Athens. The company performs clinical chemistry, immunology, microbiology, molecular diagnostics, genetics, allergy and autoimmune disease testing, accredited SARS-CoV-2 PCR, and metagenomic gut microbiome analysis (in partnership with REDLABS Belgium), serving patients directly through walk-in sample collection and the medical community through referral-based testing across Greece, Cyprus, and the Balkans.

Product overview

IN VITRO LABS S.A. operates as a full-service medical diagnostic laboratory company offering comprehensive clinical testing services. The company provides molecular diagnostics (including accredited SARS-CoV-2 testing), clinical chemistry, immunology, microbiology, genetics, and specialized diagnostic panels. Services are delivered through a network of diagnostic departments and supported by the WebLis patient portal for online result access. The company has partnered with R.E.D. Laboratories (Belgium) for advanced microbiome analysis services.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Laboratory Diagnostics Services Comprehensive medical diagnostic testing covering clinical chemistry, immunology, microbiology, molecular diagnostics, genetics, and specialized testing panels, delivered through a 1600 sq.m. ISO 15189:2012 accredited laboratory for patients and referring medical professionals in Greece, Cyprus, and the Balkans.
• WebLis Patient Portal (Infomed InVitro Labs) Multilingual online portal (Greek, English, Russian, Lithuanian) that lets patients access laboratory results, schedule appointments, and manage healthcare records from the In Vitro Labs diagnostics service.
• Molecular Diagnostics Department Specialized molecular diagnostics offering DNA/RNA testing, PCR-based assays, genetic screening panels, and one of the first ESYD-accredited SARS-CoV-2 molecular analysis workflows in Greece, operated under WHO, DCD, and FDA-aligned quality assurance protocols.
• COVID-19 Diagnostic Services

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• R.E.D. Laboratories (REDLABS)coreTechnology or IntegrationIn Vitro Labs has partnered with R.E.D. Laboratories, a Belgium-based laboratory specializing in metagenomics of gut microbiome, dysbiosis diagnosis, immunological dysfunction investigation, autism, and chronic fatigue. This partnership provides access to advanced Microbiota Stool Analysis (MSA assay) using metagenomics methodology and specialized immune dysfunction panels.

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Quest Diagnostics: One of the largest global clinical laboratory networks, offering routine and esoteric testing across multiple specialties. Relevant as a benchmark for scale, accreditation depth, and specialty testing capabilities that In Vitro Labs aspires to in its niche.
• Laboratory Corporation of America (Labcorp): Global clinical laboratory and diagnostics leader covering routine, specialty, and esoteric testing. Comparable as a broad incumbent illustrating the scale ceiling achievable in clinical diagnostics and competitive pressure on smaller regional labs.

Emerging players

• R.E.D. Laboratories: Belgium-based specialty laboratory focused on gut microbiome metagenomics, dysbiosis diagnosis, and immunological dysfunction testing. Currently a partner of In Vitro Labs and comparable in offering the niche specialty services that In Vitro Labs distributes in Greece.

Direct peers

• Cerba Healthcare: European reference and specialty laboratory group offering clinical diagnostics, molecular genetics, and infectious disease testing. Comparable in offering advanced specialty panels and serving cross-border physician referrals across Europe.
• Bioiatriki: One of the largest Greek diagnostic laboratory chains, offering clinical chemistry, immunology, microbiology, molecular diagnostics, and genetic testing across multiple sites. Directly comparable in service breadth, geography, and target customers (Greek physicians and patients).
• Synlab: Europe's leading medical diagnostic services provider, operating clinical laboratories across multiple countries including presence in Greece and the Balkans. Directly comparable multi-discipline testing menu and B2B referral model.
• Unilabs: Pan-European diagnostic laboratory group with strong presence in clinical chemistry, immunology, molecular diagnostics, and specialty testing. Comparable in service scope and multi-country European footprint overlapping with In Vitro Labs' Balkans and Cyprus claims.
• Affidea: European provider of diagnostic and outpatient services with established operations in Greece. Comparable in combining diagnostic testing with healthcare provider relationships and operating a multi-site model in overlapping geographies.

Regional players

• Euromedica: Greek healthcare group providing diagnostic laboratory services, imaging, and primary care across Greece. Comparable as a domestic Greek competitor pursuing similar physician referral and patient walk-in channels.
• Medicover: Healthcare and diagnostic services provider with significant footprint in Central and Eastern Europe, including clinical laboratory operations. Comparable in operating multi-country diagnostic networks across Eastern Europe overlapping with the Balkans target geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/in-vitro-labs-s.a.

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IN VITRO LABS S.A.